Share This Author
Neoplasie vescicali incidentali
It is concluded that incidental bladder tumours have a better prognosis than symptomatic bladder tumoured patients being examined for other pathologies, even though patient numbers were small.
Immunoterapia topica del carcinoma vescicale con KLH (keyhole limpet hemocyanin): studio controllato di fase 2
KLH appears active and non-toxic, and the result of a controlled study on patients with carcinoma in-situ is reported, indicating that KLH appears promising in the topical treatment of superficial bladder cancer.
BTA Stat e Trak nel monitoraggio del carcinoma vescicale superficiale
Results showed the usefulness of the BTA tests in monitoring superficial bladder cancer, in that an increase in BTA Trak values and positivity ofThe BTA Stat were associated with a notable increase in the risk of disease.
Epirubicina ad alte dosi: vantaggi di un trattamento dilazionato
In conclusion, the split, high-dose treatment with intravesical epirubicin of superficial bladder cancer with intermediate risk was well tolerated in terms of side effects and was effective.
Neoplasie vescicali in pazienti di età inferiore ai 40 anni
F superficial bladder cancer in young people should be treated on the basis of common prognostic factors, the therapeutic approach should be based on the grade and stage regardless of age and follow-up should be rigorous and long.